​

Ardelyx (ARDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDX Stock Forecast

Ardelyx (ARDX) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $17.00, with a high of $19.00 and a low of $15.00. This represents a 200.35% increase from the last price of $5.66.

$5 $8 $11 $14 $17 $20 High: $19 Avg: $17 Low: $15 Last Closed Price: $5.66

ARDX Stock Rating

Ardelyx stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 16 Strong Sell Sell Hold Buy Strong Buy

ARDX Price Target Upside V Benchmarks

TypeNameUpside
StockArdelyx200.35%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts269
Avg Price Target$17.50$17.00$15.33
Last Closing Price$5.66$5.66$5.66
Upside/Downside209.19%200.35%170.85%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26110---11
Feb, 26110---11
Jan, 26-101--11
Dec, 25-101--11
Nov, 25291--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 12, 2026Roanna RuizWilliams Trading$17.00$5.66200.35%200.35%
Feb 20, 2026H.C. Wainwright$18.00$6.74167.06%218.02%
Jan 27, 2026Jefferies$15.00$7.8092.31%165.02%
Jan 09, 2026Julian HarrisonBTIG$17.00$7.00142.86%200.35%
Jan 08, 2026Piper Sandler$16.00$7.00128.57%182.69%
Jan 08, 2026Christopher RaymondRaymond James$19.00$7.00171.43%235.69%
Nov 04, 2025Piper Sandler$10.00$5.8670.65%76.68%
Aug 05, 2025Wedbush$14.00$5.13172.90%147.35%
Aug 05, 2025UBS$12.00$5.13133.92%112.01%
Mar 04, 2025BTIG$14.00$5.41158.78%147.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 12, 2026Leerink PartnersOutperformOutperformhold
Feb 20, 2026H.C. WainwrightBuyBuyhold
Jan 29, 2026Cowen & Co.BuyBuyhold
Jan 27, 2026JefferiesBuyBuyhold
Jan 09, 2026CitigroupBuyBuyhold
Jan 09, 2026BTIGBuyBuyhold
Jan 08, 2026Piper SandlerNeutralOverweightupgrade
Jan 08, 2026Raymond JamesStrong BuyStrong Buyhold
Nov 25, 2025Raymond JamesStrong BuyStrong Buyhold
Nov 04, 2025Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.52$-0.42$-0.30$-0.17$-0.26---
Avg Forecast$-1.51$-0.51$-0.27$-0.17$-0.14$0.40$0.84$1.21
High Forecast$-1.17$-0.39$-0.21$-0.12$0.38$0.93$1.34$1.52
Low Forecast$-1.92$-0.70$-0.30$-0.23$-0.45$0.04$0.47$1.03
Surprise %0.66%-17.65%11.11%-85.71%---

Revenue Forecast

$0 $200M $400M $600M $800M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.10M$52.16M$124.46M$333.62M$407.32M---
Avg Forecast$9.75M$34.15M$124.20M$327.18M$374.66M$503.68M$650.81M$797.50M
High Forecast$11.74M$44.16M$127.81M$341.44M$410.26M$512.36M$669.84M$952.97M
Low Forecast$8.04M$28.01M$122.28M$314.26M$342.01M$495.00M$631.79M$704.65M
Surprise %3.56%52.74%0.20%1.97%8.72%---

Net Income Forecast

$-200M $-90M $20M $130M $240M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-158.16M$-67.21M$-66.07M$-39.14M$-61.60M---
Avg Forecast$-135.94M$-138.92M$-66.07M$-38.82M$-45.84M$83.22M$207.57M$265.76M
High Forecast$-108.75M$-111.14M$-52.85M$-26.62M$83.49M$204.48M$294.88M$333.11M
Low Forecast$-163.13M$-166.71M$-79.28M$-51.03M$-98.10M$8.18M$103.80M$225.54M
Surprise %16.35%-51.62%0.00%0.80%34.39%---

ARDX Forecast FAQ

Is Ardelyx stock a buy?

Ardelyx stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ardelyx is a favorable investment for most analysts.

What is Ardelyx's price target?

Ardelyx's price target, set by 16 Wall Street analysts, averages $17 over the next 12 months. The price target range spans from $15 at the low end to $19 at the high end, suggesting a potential 200.35% change from the previous closing price of $5.66.

How does Ardelyx stock forecast compare to its benchmarks?

Ardelyx's stock forecast shows a 200.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Ardelyx over the past three months?

  • March 2026: 9.09% Strong Buy, 90.91% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 9.09% Strong Buy, 90.91% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 90.91% Buy, 9.09% Hold, 0% Sell, 0% Strong Sell.

What is Ardelyx’s EPS forecast?

Ardelyx's average annual EPS forecast for its fiscal year ending in December 2026 is $0.4, marking a -253.85% decrease from the reported $-0.26 in 2025. Estimates for the following years are $0.84 in 2027, and $1.21 in 2028.

What is Ardelyx’s revenue forecast?

Ardelyx's average annual revenue forecast for its fiscal year ending in December 2026 is $503.68M, reflecting a 23.66% increase from the reported $407.32M in 2025. The forecast for 2027 is $650.81M, and $797.5M for 2028.

What is Ardelyx’s net income forecast?

Ardelyx's net income forecast for the fiscal year ending in December 2026 stands at $83.22M, representing a -235.10% decrease from the reported $-61.599M in 2025. Projections indicate $207.57M in 2027, and $265.76M in 2028.